Company News

EN

News

Company News

News

Company News

MicroPort EP Successfully Performed First Procedures in Poland

Sandomierz , Poland——Recently, the electrophysiologists in EP Lab, Sandomierz used the products independently developed by MicroPort EP.

12-17

2021
MicroPort EP Products Debut in First Procedure in Chile

La Serena，Chile—MicroPort EP announced to successfully complete a Paroxysmal Supraventricular Tachycardia (SVT) treatment in Chile with its FireMagic™ Cardiac RF Ablation Catheter and the EasyFinder™ Steerable Curve Diagnostic Catheters, which was the first procedure in Chile since its entry into the country.

12-17

2021
STEREOTAXIS ROBOTIC TECHNOLOGY REDUCES INCIDENCE OF SILENT CEREBRAL EMBOLISM DURING ATRIAL FIBRILLATION ABLATION IN NEW PEER-REVIEWED PUBLICATION

Dec. 08, 2021，The strategic partner of MicroPort EP——Stereotaxis, announced a publication in Frontiers in Cardiovascular Medicine titled “Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.”

12-08

2021
MicroPort EP Successfully held EP workshop in Italy

Recently，MicroPort EP European Team completed the EP workshop in the EP training center in Bergamo Gavazzeni hospital.The workshop has covered all CE marked productThe workshop has covered all CE marked products which are independently developed by Shanghai MicroPort EP MedTech Co., Ltd.

11-13

2021
MicroPort EP Successfully Performed First Atrial Fibrillation Cases in Russia

Recently, the electrophysiologists in First St Petersburg State Medical University named after Pavlov Hospital used a full range of products including Columbus™ 3D EP Navigation System , FireMagic™ 3D Irrigated RF Ablation Catheter which are independently developed by MicroPort EP , to successfully complete 4 Atrial Fibrillation procedures.

11-05

2021
MicroPort EP Products Debut in First Procedure in Kazakhstan

MicroPort EP announced to complete the first procedure in Kazakhstan with its three products, including the FireMagic™ Cardiac RF Ablation Catheter, the EasyFinder™ Steerable Curve Diagnostic Catheter, the PathBuilder™ Steerable Introducer and PathBuilder™ Transseptal Guiding Introducer and PathBuilder™ Transseptal Needle.

09-01

2021

Prev 4 5 6 7 8 9 10 11 12 ... Next

Tel：

(86)(21)60969600

Add: Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China

Legal Statement

Website License Number：Shanghai ICP Record No.16034362

Internet Drug Information Service Qualification Certificate Number: (Shanghai) - non operational - 2016-0126

            
Home

Tel

Top

EN

Home

About Us

Company Profile

Milestone

Awards

Products

Navigational Solutions

Conventional Solutions

News

Company News

Contact Us

News

News

MicroPort EP Successfully Performed First Procedures in Poland

Sandomierz , Poland——Recently, the electrophysiologists in EP Lab, Sandomierz used the products independently developed by MicroPort EP.

MicroPort EP Products Debut in First Procedure in Chile

STEREOTAXIS ROBOTIC TECHNOLOGY REDUCES INCIDENCE OF SILENT CEREBRAL EMBOLISM DURING ATRIAL FIBRILLATION ABLATION IN NEW PEER-REVIEWED PUBLICATION

Dec. 08, 2021，The strategic partner of MicroPort EP——Stereotaxis, announced a publication in Frontiers in Cardiovascular Medicine titled “Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.”

MicroPort EP Successfully held EP workshop in Italy

Recently，MicroPort EP European Team completed the EP workshop in the EP training center in Bergamo Gavazzeni hospital.The workshop has covered all CE marked productThe workshop has covered all CE marked products which are independently developed by Shanghai MicroPort EP MedTech Co., Ltd.

MicroPort EP Successfully Performed First Atrial Fibrillation Cases in Russia

MicroPort EP Products Debut in First Procedure in Kazakhstan